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Synaesthesia as a genetic trait 
It was first noted over a century ago that synaesthesia runs in families. This 
suggests that genetic factors play an important role in an individual's likelihood of 
developing synaesthesia. However, specific genetic variants that predispose to 
synaesthesia have yet to be discovered, and the genetic foundations are likely to 
be complex and to vary among individuals. We are using state-of-the-art genome-
wide approaches to investigate the genetic basis of synaesthesia.  
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Discovering rare genetic variants: exome sequencing 
The human genome contains over 20,000 genes, each of which encodes the instructions to 
make a protein – a molecular machine with a specialized function in the body.  The protein-
coding sections of the genome are collectively referred to as the exome.  The exome makes 
up less than 2% of the total genome, but it is where rare variants with large effects on 
biological traits are most likely to be found. 
Using next-generation DNA sequencing technology, we are sequencing the exomes of 
individuals from families in which multiple people have synaesthesia.  We then screen the 
sequences for rare genetic variants that are shared by related synaesthetes, and may 
therefore contribute to synaesthesia in these families. By looking at the function of the 
genes affected by these rare variants, we can learn about the molecular processes that 
underlie synaesthesia.  
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Perspectives 
Association studies and exome sequencing provide two complementary approaches to 
identify genes that may be involved in synaesthesia.  Findings from these two approaches 
will be integrated to assess whether they converge on the same biological pathways.   
The identification of specific genes and gene networks involved in synaesthesia will for the 
first time shed light on the molecular basis of this intriguing neurodevelopmental condition.  
In addition, it may also have wider implications for neurobiology, contributing to our 
understanding of how neural connectivity is established in the developing brain. 
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Test group Control group 
We can do an association study using a small number of candidate SNPs chosen on the 
basis of a specific biological hypothesis.  In the case of synaesthesia, for example, we might 
want to test if SNPs in a gene involved in neural connectivity are associated with 
synaesthesia.  To do this, we would need DNA from around 200 synaesthetes. 
Because no-one is certain about which kinds of genes might be involved in synaesthesia, 
we would also like to do a genome-wide association study or GWAS, in which thousands of 
SNPs from across the entire genome are tested simultaneously for association.  The results 
of a GWAS are often represented using a Manhattan plot like the one shown below.  By 
looking at the functions of the genes that lie in the association peaks, we can gain new 
insights into the biological basis of synaesthesia.   To perform a GWAS we would need DNA 
from a least 1000 synaesthetes.   
By statistically comparing the frequencies of the two different versions of a common SNP in 
a group of people who have a particular trait (eg. synaesthesia) with a group of people who 
don’t (the control group), we can determine if the region of the genome around the SNP 
may be involved in the trait.  This is called an association test. In the illustration below, the 
C variant is present significantly more frequently in the test group than the control group, 
so we would conclude that the C variant is associated with the trait found in the test group.  
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Human genetic variation 
DNA is a long chain composed of four different kinds of nucleotide: A, T, C and G. The 
human genome contains 3 billion nucleotides.  Even though 99.9% of the genome is the 
same across the whole human population, every individual has millions of differences 
(variants) compared to the reference sequence.   
Many of these nucleotide differences are common variants, often called single-nucleotide 
polymorphisms or SNPs, which means that at least 1 person in 100 has a different 
nucleotide to the reference sequence.  There are also rare variants, which are found in less 
than 1% of the population, and possibly only in one individual or their family.   
We are using different technologies to look at both common variants and rare variants, to 
assess their role in synaesthesia. 
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Analyse the function of these candidate genes.  
Characterizing synaesthesia for genetic studies 
For genetic studies involving large 
numbers of individuals, it is 
important to be able to assess the 
trait of interest in a quick and 
consistent way.  For this reason, we 
focus on grapheme-colour 
synaesthesia, and we ask everyone 
who takes part in our research to 
complete the Synaesthesia Battery.  
This includes tasks such as the 
Colour Picker Test (right), which 
gives a score based on consistency 
of grapheme-colour associations. 
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The Colour Picker Test 
http://synesthete.org 
Take part in our research! 
To enable us to investigate the genetic basis of synaesthesia we need: 
• Large numbers of unrelated synaesthetes for association studies. 
• Families with several synaesthetes and non-synaesthetes for exome sequencing. 
 
Researchers: We are interested to hear from researchers who work with synaesthetes 
who may like to participate in our genetic studies. 
Synaesthetes: Join our study! You do not have to travel to take part. We will assess 
your synaesthetic experiences online and provide a saliva kit by post to obtain your 
DNA (this is completely painless!).  
 
Contact: synaesthesia@mpi.nl 
Visit www.mpi.nl/synaesthesia for information 
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